Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Immunic (IMUX)

Immunic Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMUX
DateTimeSourceHeadlineSymbolCompany
13/01/202513:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
07/01/202511:30PR Newswire (US)Immunic Highlights 2024 Accomplishments and Upcoming MilestonesNASDAQ:IMUXImmunic Inc
18/12/202421:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
09/12/202413:30Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IMUXImmunic Inc
06/12/202422:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/202422:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
06/12/202422:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
26/11/202411:30PR Newswire (US)Immunic, Inc. to Participate in Investor Conference in DecemberNASDAQ:IMUXImmunic Inc
14/11/202422:33Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IMUXImmunic Inc
14/11/202411:58Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IMUXImmunic Inc
13/11/202419:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMUXImmunic Inc
13/11/202411:30PR Newswire (US)Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & HepatologyNASDAQ:IMUXImmunic Inc
12/11/202414:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IMUXImmunic Inc
07/11/202412:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMUXImmunic Inc
07/11/202411:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
07/11/202411:30PR Newswire (US)Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IMUXImmunic Inc
31/10/202410:30PR Newswire (US)Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate UpdateNASDAQ:IMUXImmunic Inc
29/10/202410:30PR Newswire (US)Immunic to Participate in Industry, Scientific and Investor Conferences in NovemberNASDAQ:IMUXImmunic Inc
22/10/202410:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
22/10/202410:30PR Newswire (US)Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple SclerosisNASDAQ:IMUXImmunic Inc
18/09/202410:30PR Newswire (US)Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple SclerosisNASDAQ:IMUXImmunic Inc
10/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
04/09/202410:30PR Newswire (US)Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID SyndromeNASDAQ:IMUXImmunic Inc
03/09/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
28/08/202410:30PR Newswire (US)Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in SeptemberNASDAQ:IMUXImmunic Inc
08/08/202411:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMUXImmunic Inc
08/08/202410:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMUXImmunic Inc
08/08/202410:30PR Newswire (US)Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:IMUXImmunic Inc
 Showing the most relevant articles for your search:NASDAQ:IMUX